| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 1 | -10,000 | 100% | $28.03 | -$280,280 |
| Net | -1 | -10,000 | -100% | -$280,280 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Todd C. Davis | Director | $15,258,615 | 02 Jul 2025 | ||
| LIGAND PHARMACEUTICALS INC | Director, 10%+ Owner | $15,000,000 | 17 Dec 2025 | ||
| Ezra M. Friedberg | Director | $4,482,195 | -$280,281 | -5.9% | 25 Nov 2025 |
| Motif Pharmaceuticals Ltd. | 10%+ Owner | $2,259,235 | 15 Feb 2024 | ||
| Boswell Prayer Ltd. | 10%+ Owner | $2,207,496 | 15 Feb 2024 | ||
| Aperture Healthcare Ventures Ltd. | 10%+ Owner | $2,047,517 | 15 Feb 2024 | ||
| AME Equities LLC | 10%+ Owner | $1,685,582 | 15 Feb 2024 | ||
| Andrew J. Einhorn | Director | $342,000 | 23 Dec 2025 | ||
| Richard Malamut | Director | $199,116 | 02 Jul 2025 | ||
| Francis Knuettel II | CFO, Treas & Secty | $114,097 | 02 Jul 2025 | ||
| Matthew Pauls | Director | $30,609 | 10 Dec 2025 | ||
| Chia-Lin Simmons | Director | 11 Apr 2025 | |||
| Eric Lang | Chief Medical Officer | 14 Jun 2024 | |||
| Peter S. Greenleaf | Director | 02 Jul 2025 | |||
| Scott M. Plesha | CEO and President, Director | 02 Jul 2025 | |||
| Richard Baxter | Director | 02 Jul 2025 | |||
| Sai Rangarao | Chief Commercial Officer | 02 Jul 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|